Stanistreet B, et al. An evidence-based review of elevated blood pressure for the inpatient. Am J Med. 2020;133(2):165-169.
Axon RN, et al. Prevalence and management of hypertension in the inpatient setting: a systematic review. J Hosp Med. 2011;6(7):417-422.
Centers for Disease Control and Prevention. National Center for Health Statistics. 2020–2021. Accessed April 3, 2023. https://www.cdc.gov/nchs/data/hus/2020-2021/HospAdmis.pdf
Rastogi R, et al. Treatment and outcomes of inpatient hypertension among adults with noncardiac admissions. JAMA Intern Med. 2021;181(3):345-352.
Anderson TS, et al. Clinical outcomes of intensive inpatient blood pressure management in hospitalized older adults. JAMA Intern Med. 2023;183(7):715-723.
Nakprasert P, et al. Effect of predischarge blood pressure on follow-up outcomes in patients with severe hypertension in the ED. Am J Emerg Med. 2016;34(5):834-839.
Patel KK, et al. Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting. JAMA Intern Med. 2016;176(7):981-988.
Levy PD, et al. Blood pressure treatment and outcomes in hypertensive patients without acute target organ damage: a retrospective cohort. Am J Emerg Med. 2015;33(9):1219-1224.
Lipari M, et al. As-needed intravenous antihypertensive therapy and blood pressure control. J Hosp Med. 2016;11(3):193-198.
Park SK, et al. Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial. J Hypertens. 2017;35(7):1474-1480.
Breu AC, et al. Acute treatment of hypertensive urgency. J Hosp Med. 2018;13(12):860-862.
Axon RN, et al. An update on inpatient hypertension management. Curr Cardiol Rep. 2015;17(11):94.
Campos CL, et al. Pharmacologic treatment of hypertensive urgency in the outpatient setting: a systematic review. J Gen Intern Med. 2018;33(4):539-550.
Dhatariya K, et al. Management of Diabetes and Hyperglycemia in Hospitalized Patients. MDText.com; 2020. Accessed January 15, 2023. https://www.ncbi.nlm.nih.gov/books/NBK279093/
Dhatariya K, et al. Safe care for people with diabetes in hospital. Clin Med (Lond). 2020;20(1):21-27.
Seisa MO, et al. A systematic review supporting the Endocrine Society clinical practice guideline for the management of hyperglycemia in adults hospitalized for noncritical illness or undergoing elective surgical procedures. J Clin Endocrinol Metab. 2022;107(8):2139-2147.
Korytkowski MT, et al. Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2022;107(8):2101-2128.
Finfer S, et al.; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297.
ElSayed NA, et al.; American Diabetes Association. 16. diabetes care in the hospital: standards of care in diabetes–2023. Diabetes Care. 2023;46(suppl 1):S267-S278.
Umpierrez GE, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181-2186.
Galindo RJ, et al. Safety and efficacy of inpatient diabetes management with non-insulin agents: an overview of international practices. Curr Diab Rep. 2022;22(6):237-246.
Migdal AL, et al. Inpatient glycemic control with sliding scale insulin in noncritical patients with type 2 diabetes: who can slide?. J Hosp Med. 2021;16(8):462-468.
Inzucchi SE. Management of diabetes mellitus in hospitalized patients. July 25, 2023. Accessed January 20, 2023. https://www.uptodate.com/contents/management-of-diabetes-mellitus-in-hospitalized-patients
Demidowich AP, et al. Effects of a dedicated inpatient diabetes management service on glycemic control in a community hospital setting. J Diabetes Sci Technol. 2021;15(3):546-552.
Parthvi R, et al. Update on phenobarbital for alcohol withdrawal syndrome in intensive care. J Clin Intensive Care Med. 2019;4:036-039.
Wood E, et al. Will this hospitalized patient develop severe alcohol withdrawal syndrome?: The rational clinical examination systematic review [published correction appears in JAMA. 2019; 322(4): 369]. JAMA. 2018;320(8):825-833.
Doering-Silveira J, et al. Assessing alcohol dependence in hospitalized patients. Int J Environ Res Public Health. 2014;11(6):5783-5791.
Gortney JS, et al. Alcohol withdrawal syndrome in medical patients. Cleve Clin J Med. 2016;83(1):67-79.
Sachdeva A, et al. Alcohol withdrawal syndrome: benzodiazepines and beyond. J Clin Diagn Res. 2015;9(9):VE01-VE07.
Muncie HL, et al. Outpatient management of alcohol withdrawal syndrome. Am Fam Physician. 2013;88(9):589-595.
Maldonado JR, et al. Prospective validation study of the prediction of Alcohol Withdrawal Severity Scale (PAWSS) in medically ill inpatients: a new scale for the prediction of complicated alcohol withdrawal syndrome. Alcohol Alcohol. 2015;50(5):509-518.
The ASAM clinical practice guideline on alcohol withdrawal management [published correction appears in J. Addict Med. 2020; 14(5): e280]. J Addict Med. 2020;14(3S supp 1):1-72.
Cohen SM, et al. The spectrum of alcohol use: epidemiology, diagnosis, and treatment. Med Clin North Am. 2022;106(1):43-60.
Chand PK, et al. Management of alcohol withdrawal syndrome in patients with alcoholic liver disease. J Clin Exp Hepatol. 2022;12(6):1527-1534.
Farkas J. Phenobarbital monotherapy for alcohol withdrawal: simplicity and power. October 18, 2015. Accessed January 17, 2023. https://emcrit.org/pulmcrit/phenobarbital-monotherapy-for-alcohol-withdrawal-simplicity-and-power
Nguyen TA, et al. Phenobarbital and symptom-triggered lorazepam versus lorazepam alone for severe alcohol withdrawal in the intensive care unit. Alcohol. 2020;82:23-27.
Nelson AC, et al. Benzodiazepines vs barbiturates for alcohol withdrawal: analysis of 3 different treatment protocols. Am J Emerg Med. 2019;37(4):733-736.
Sullivan SM, et al. Comparison of phenobarbital-adjunct versus benzodiazepine-only approach for alcohol withdrawal syndrome in the ED. Am J Emerg Med. 2019;37(7):1313-1316.
Oks M, et al. The safety and utility of phenobarbital use for the treatment of severe alcohol withdrawal syndrome in the medical intensive care unit. J Intensive Care Med. 2020;35(9):844-850.
Hammond DA, et al. Patient outcomes associated with phenobarbital use with or without benzodiazepines for alcohol withdrawal syndrome: a systematic review. Hosp Pharm. 2017;52(9):607-616.
Umar Z, et al. Phenobarbital and alcohol withdrawal syndrome: a systematic review and meta-analysis. Cureus. 2023;15(1):e33695.
Pistore A, et al. A retrospective evaluation of phenobarbital versus benzodiazepines for treatment of alcohol withdrawal in a regional Canadian emergency department. Alcohol. 2022;102:59-65.
Ibarra F. Single dose phenobarbital in addition to symptom-triggered lorazepam in alcohol withdrawal. Am J Emerg Med. 2020;38(2):178-181.
Nisavic M, et al. Use of phenobarbital in alcohol withdrawal management – a retrospective comparison study of phenobarbital and benzodiazepines for acute alcohol withdrawal management in general medical patients. Psychosomatics. 2019;60(5):458-467.
Minozzi S, et al. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev. 2010(3):CD005064.
Reus VI, et al. The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry. 2018;175(1):86-90.
- Neeman E, Liu V, Mishra P, et al. Trends and risk factors for venous thromboembolism among hospitalized medical patients. JAMA Netw Open. 2022;5(11):e2240373. [corrected]
Al Yami MS, et al. Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis. J Thromb Thrombolysis. 2018;45(1):36-47.
Schünemann HJ, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients [published correction appears in Blood Adv. 2023; 7(9): 1671]. Blood Adv. 2018;2(22):3198-3225.
Farge D, et al.; International Initiative on Thrombosis and Cancer (ITAC) Advisory Panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022;23(7):e334-e347.
O’Toole RV, et al.; Major Extremity Trauma Research Consortium (METRC). Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture. N Engl J Med. 2023;388(3):203-213.
Umerah CO, et al. Anticoagulation. In: StatPearls. StatPearls Publishing; 2023.
Aggarwal A, et al. Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review. World J Gastroenterol. 2014;20(19):5737-5745.
Streiff MB, et al. Update on guidelines for the management of cancer-associated thrombosis. Oncologist. 2021;26(1):e24-e40.
Zayed Y, et al. Extended duration of thromboprophylaxis for medically ill patients: a systematic review and meta-analysis of randomised controlled trials. Intern Med J. 2020;50(2):192-199.
Amsterdam EA, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes [published correction appears in J Am Coll Cardiol. 2014; 64(24): 2713–2714]. J Am Coll Cardiol. 2014;64(24):e139-e228.